September 13, 2024 by Dana-Farber Cancer Institute A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with advanced HER2-positive breast cancer. The findings, from an international clinical trial led by Dana-Farber Cancer Institute researchers, reinforce earlier...
September 12, 2024 by Diabetologia Credit: Unsplash/CC0 Public DomainSemaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) held in Madrid,...
September 11, 2024by Diabetologia Credit: Unsplash/CC0 Public DomainAs more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged. Now real-world evidence from the FDA Adverse Event Reporting System (FAERS) database reveals a reassuring safety profile for tirzepatide...
September 11, 2024 by Diabetologia Credit: Pixabay/CC0 Public DomainThe anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don’t have diabetes, whether or not they also have impaired kidney function, according to new research to be...
SEPTEMBER 9TH, 2024POSTED BY NATIONAL UNIVERSITY OF SINGAPORE. (Credit: Getty Images) TAGS : GUT BACTERIA SLEEPUNIVERSITY : NATIONAL UNIVERSITY OF SINGAPORE Researchers have found that a naturally occurring supplement can improve sleep quality in older adults, particularly in individuals with poor sleep patterns, and manage their gut microbiome composition. Ensuring good sleep quality is an...
By Bronwyn ThompsonSeptember 09, 2024 The race is on to get the first GLP-1 weight-loss medication onto the market Depositphotos The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current injectable drugs on the market, with the latest strong trial results from US...
News Release 10-Sep-2024 Reports and ProceedingsEuropean Respiratory Society image: Portrait of researcher Professor Jan Hedner Credit: Jan Hedner / European Respiratory Society Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnoea (OSA), according to results of a clinical trial presented at the European Respiratory...
September 9, 2024 by Claire Kowalick, University of Texas Health Science Center at San Antonio Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal mechanistic insights. Credit: PLOS ONE (2024). DOI: 10.1371/journal.pone.0307154Ronald Rodriguez, MD, Ph.D., professor of medical education and urology at Joe...
September 9, 2024 by King’s College London A new study from King’s College London shows that off-label prescriptions of a common antidepressant doesn’t help breathlessness in patients with respiratory disease—and may cause side effects. Researchers warn prescribing medicines for a use which it has not been licensed could make things worse, even though the prescriber...
September 4, 2024 by Steve Macfarlane, The Conversation Credit: Unsplash/CC0 Public DomainA Korean study published recently suggests that people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower risk of dementia. The researchers compared the health outcomes of more than 110,000 people aged 40–69 with type...
